2025 annual financial data
Tempest Therapeutics 2025 Operating margin
Tempest Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -26,575,000 USD and net income was -26,262,000 USD.
Operating cash flow was -26,820,000 USD.
Get free Tempest Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,575,000 USD
- Net income
- -26,262,000 USD
- Operating cash flow
- -26,820,000 USD